BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31842662)

  • 1. Thromboelastography versus bleeding time for risk of bleeding post native kidney biopsy.
    Gal-Oz A; Papushado A; Kirgner I; Meirsdorf S; Schwartz D; Schwartz IF; Zubkov A; Grupper A
    Ren Fail; 2020 Nov; 42(1):10-18. PubMed ID: 31842662
    [No Abstract]   [Full Text] [Related]  

  • 2. Desmopressin and bleeding risk after percutaneous kidney biopsy.
    Athavale A; Kulkarni H; Arslan CD; Hart P
    BMC Nephrol; 2019 Nov; 20(1):413. PubMed ID: 31730448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial.
    Manno C; Bonifati C; Torres DD; Campobasso N; Schena FP
    Am J Kidney Dis; 2011 Jun; 57(6):850-5. PubMed ID: 21354681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study.
    Peters B; Hadimeri H; Mölne J; Nasic S; Jensen G; Stegmayr B
    Nephrology (Carlton); 2018 Apr; 23(4):366-370. PubMed ID: 28107603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleeding Complications and Adverse Events After Desmopressin Acetate for Percutaneous Renal Transplant Biopsy.
    Ho QY; Lim CC; Thangaraju S; Siow B; Chin YM; Hao Y; Lee PH; Foo M; Tan CS; Kee T
    Ann Acad Med Singap; 2020 Feb; 49(2):52-64. PubMed ID: 32246706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography for the prediction of bleeding after transplant renal biopsy.
    Davis CL; Chandler WL
    J Am Soc Nephrol; 1995 Oct; 6(4):1250-5. PubMed ID: 8589293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia.
    Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS
    Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleeding Risk Assessment and the Role of Primary Hemostasis Screening in Patients Undergoing Kidney Biopsy.
    Rottenstreich A; Schwartz A; Kalish Y; Shai E; Appelbaum L; Bdolah-Abram T; Sagiv I
    Isr Med Assoc J; 2018 Aug; 20(8):499-503. PubMed ID: 30084576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thromboelastography is a suboptimal test for determination of the underlying cause of bleeding associated with cardiopulmonary bypass and may not predict a hypercoagulable state.
    Welsh KJ; Padilla A; Dasgupta A; Nguyen AN; Wahed A
    Am J Clin Pathol; 2014 Oct; 142(4):492-7. PubMed ID: 25239416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of bleeding times on major complication rates after percutaneous real-time ultrasound-guided renal biopsies.
    Stiles KP; Hill C; LeBrun CJ; Reinmuth B; Yuan CM; Abbott KC
    J Nephrol; 2001; 14(4):275-9. PubMed ID: 11506250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Vuyyuru SK; Singh AD; Gamanagatti SR; Rout G; Gunjan D; Shalimar
    Dig Dis Sci; 2020 Jul; 65(7):2104-2111. PubMed ID: 31720889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal transplant biopsy complications: assessment of risk factors and potential of desmopressin to decrease risk of hemorrhage.
    Peters B; Nasic S; Jensen G; Stegmayr B
    Acta Radiol; 2020 Dec; 61(12):1717-1723. PubMed ID: 32212828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: a systematic review.
    Lim CC; Tan HZ; Tan CS; Healy H; Choo J; Franca Gois PH
    Intern Med J; 2021 Apr; 51(4):571-579. PubMed ID: 32040251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the bleeding time predictive of bleeding prior to a percutaneous renal biopsy?
    Mattix H; Singh AK
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):715-8. PubMed ID: 10630818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring hemoglobin prior to early discharge without routine surveillance ultrasound after percutaneous native renal biopsy in children.
    Muthusami P; Sunder S; Gallibois C; Kitamura E; Parra D; Amaral J; John P; Noone D; Connolly B
    Pediatr Nephrol; 2017 Oct; 32(10):1927-1934. PubMed ID: 28477259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between thromboelastography and conventional coagulation tests after cardiopulmonary bypass surgery in the paediatric intensive care unit.
    Pekelharing J; Furck A; Banya W; Macrae D; Davidson SJ
    Int J Lab Hematol; 2014 Aug; 36(4):465-71. PubMed ID: 24325756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboelastography can Identify Postoperative Active Bleeding and Evaluate Blood Product Requirements in Abdominal Surgery.
    Zhang JJ; Yu WK; Gao T; Xi FC; Zhu WM; Li N; Li JS
    Hepatogastroenterology; 2014 May; 61(131):628-32. PubMed ID: 26176047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboelastography for predicting bleeding in patients with aortic stenosis treated with transcatheter aortic valve implantation.
    Rymuza B; Zbroński K; Scisło P; Grodecki K; Kochman J; Filipiak KJ; Opolski G; Huczek Z
    Kardiol Pol; 2018; 76(2):418-425. PubMed ID: 29192952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimation of risk for major bleeding in native kidney biopsies in patients with multiple risk factors.
    Lim CC; Tan RY; Choo JCJ; Tan HZ; Mok I; Chin YM; Tan CS
    Int Urol Nephrol; 2022 Feb; 54(2):343-348. PubMed ID: 33913059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.